-
未分類
Poster presentation at the 14th Australian Peptide Conference.
Veneno Technoloiges will participate the 14th Australian Peptide Conference to be held in Gold Coast, Australia to be held in Gold Coast, Australia.Dr. Taira, Director, […]-
YoshikawaKazunori
-
-
未分類
Introduced as a remarkable AIST venture.
Veneno Technologies is introduced as a bio-venture that provides a new drug discovery platform based on research on tarantula venom at AIST (The National Institute […]-
YoshikawaKazunori
-
-
未分類
Opened new laboratory.
Veneno Technologies Corporation is pleased to announce the opening of our laboratory in Tsukuba Center Inc.Address: 2-1-6 Sengen, Tsukuba City, Ibaraki Prefecture, 305-0047, Japan-
YoshikawaKazunori
-
-
未分類
Published in the Nikkei Biotech ONLINE
On January 24, 2022, an article introducing our company, “Veneno Technologies, a peptide drug discovery company, raises 200 million yen in seed round.” was published […]-
YoshikawaKazunori
-
-
未分類
Veneno Technologies raised 200M Yen ($2M) Seed Funding Round
Veneno Technologies Co. Ltd. is pleased to announce that it has completed fundraising of 200 million yen through a third-party allocation of new shares to […]-
管理者
-
-
未分類
We were selected as a Top 10 BioTech Startups In APAC – 2021 COMPANY OF THE YEAR by Life Sciences Review.
We are pleased to announce that we have been selected as COMPANY OF THE YEAR in the Top 10 BioTech Startups In APAC – 2021 […]-
管理者
-
-
未分類
Concluded an agreement with NAGASE & CO., LTD. on agency and capital alliance in the DRP drug discovery business
Veneno Technologies Co. Ltd. and NAGASE & CO., LTD. announced that both companies have entered into a distributorship and capital alliance agreement for DRP functional […]-
管理者
-
YoshikawaKazunori 
管理者